Dr. Chris Meier is a Managing Director & Partner at Boston Consulting Group (BCG), headquartered in London, where he leads their Health Care practice’s medical and innovation efforts and serves as global head of AI, data, and analytics in the biopharma sector. Holding a PhD in Structural Biology from the University of Oxford and an MBA from London Business School, he previously worked as a principal scientist in pharmaceutical drug-discovery research, contributing to the development of multiple molecules for autoimmune diseases and oncology.